Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Financial Results

Aspira Pathlab & Diagnostics Financial Results

Aspira Pathlab approved its audited standalone financial results for the year ended March 31, 2026. The board also appointed new management and an internal auditor.

Source

BSE filing, NSE: ASPIRA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Aspira Pathlab & Diagnostics Ltd: key numbers

Share price
₹125.65
Market cap
₹129.3 Cr
Revenue (annual)
₹24.98 Cr
Net profit (annual)
₹0.05 Cr
P/E (TTM)
-285.8×Sector 52.0×
Promoter holding
46.65%+0.07% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Aspira Pathlab & Diagnostics Ltd

All →

Other financial results announcements

All →